{"name":"Proximagen Limited","slug":"proximagen-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNdzVlVEdXM1ZPOUFvN0pzV0xBS1BjMllJRVVMQjJnVWRObE9Zd01jeGJfVWZXTTFHdUlPOXd6UGZxMkNWN0JhYmVSTFlVU2ZqY1Z6Szlkb0RFR25adVNra1JIT2QtZERxQlJaR09rZVdObXVuQ1RkX2JEbXRueUZlNkJoWUJzU2xkNEJFTXpMX1VYM3ZIaVR6cWlpM2dhREVGcWRPQmk5OTdjVFlxMFVleA?oc=5","date":"2018-02-26","type":"deal","source":"Fierce Biotech","summary":"BenevolentAI's Proximagen buy creates first AI firm capable of entire drug R&D - Fierce Biotech","headline":"BenevolentAI's Proximagen buy creates first AI firm capable of entire drug R&D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPRVhkMkhubWo2dnA0ZzZBQ0laMkJOT3VfMHFWUXRkeXFvUDc0Zk12eVRHYWdwU1B0VXhPTnZfX3AxeTVaSDV1RW8wenE4VU51UnVoc2pCVjB6azZJcjhkeklrY0k3dlpmbzkyUUVpa3VMSGxOTWI5Ni1ES0g2bWk4TGY1WXhjRTdWZWlsUm1xTDQ?oc=5","date":"2017-04-27","type":"trial","source":"drugdiscoverytrends.com","summary":"Midazolam Nasal Spray Trial Meets Primary Endpoint - drugdiscoverytrends.com","headline":"Midazolam Nasal Spray Trial Meets Primary Endpoint","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}